Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation

Eye

Volumn 24, Issue 4, 2010, Pages 713-716

  Han, D P ^a   McAllister, J T ^a   Weinberg, D V ^a   Kim, J E ^a   Wirostko, W J ^a  

^a EYE INSTITUTE   (United States)

Author keywords

Age related macular degeneration; Anti VEGF therapy; Degenerative myopia; Extrafoveal choroidal neovascularization; Ocular histoplasmosis; Photodynamic therapy

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VERTEPORFIN;

ARTICLE; CLINICAL ARTICLE; DEGENERATIVE MYOPIA; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LASER COAGULATION; OCULAR HISTOPLASMOSIS; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 77951107292     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.122     Document Type: Article

References (8)

1. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Arch Ophthalmol 1986; 104: 694-701.
2. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1990; 108: 816-824.
3. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 1987; 105: 1499-1507.
4. Han DP, Folk JC, Bratton AR. Visual loss after successful photocoagulation of choroidal neovascularization. Ophthalmology 1988; 95: 1380-1384.
5. Virgili G, Menchini F. Laser photocoagulation for choroidal neovascularisation in pathologic myopia. Cochrane Database Syst Rev 2005; (4): CD004765 (web-access only).
6. Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007; 144: 850-857.
7. Lazic R, Gabric N, Dekaris I, Gavric M, Bosnar D. Photodynamic therapy combined with intravitreal bevacizumab (Avastin) in treatment of choroidal neovascularization secondary to age-related macular degeneration. Collegium Antropologicum 2007; 31(Suppl 1): 71-75.
8. Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, et al., FOCUS Study Group. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol 2006; 124: 1532-1542